首页> 外国专利> System and method for detecting pulmonary edema based on impedance measured using an implantable medical device during a lead maturation interval

System and method for detecting pulmonary edema based on impedance measured using an implantable medical device during a lead maturation interval

机译:基于在铅成熟间隔期间使用可植入医疗设备测量的阻抗来检测肺水肿的系统和方法

摘要

Techniques are provided for use by implantable medical devices such as cardiac resynchronization therapy (CRT) devices for detecting pulmonary edema based on transthoracic impedance sensed using cardiac pacing/sensing leads, wherein detection can be performed while lead maturation occurs. Briefly, the implantable device determines whether the leads are within an initial post-implant interval following implant during which lead maturation generally occurs. The device then detects pulmonary edema or related medical conditions within the patient based on transthoracic impedance using a set of detection parameters adjusted for use during the post-implant interval. Thus, rather than “blanking” impedance data during lead maturation, the device instead detects and processes impedance during this period to identify possible episodes of pulmonary edema so that appropriate measures can be undertaken, such as delivery of warnings or titration of appropriate medications.
机译:提供了由诸如心脏再同步治疗(CRT)设备之类的可植入医疗设备使用的技术,该技术用于基于使用心脏起搏/感测导线感测到的经胸阻抗来检测肺水肿,其中可以在导线成熟时进行检测。简而言之,可植入装置确定导线是否在植入后的初始植入后间隔内,在此间隔期间通常会发生导线成熟。然后,该设备基于经胸阻抗,使用一组为在植入后间隔期间使用而调整的检测参数,来检测患者的肺水肿或相关医学状况。因此,该设备不是在铅成熟期间“屏蔽”阻抗数据,而是在此期间检测和处理阻抗以识别可能的肺水肿发作,从而可以采取适当的措施,例如发出警告或滴定适当的药物。

著录项

  • 公开/公告号US8983605B2

    专利类型

  • 公开/公告日2015-03-17

    原文格式PDF

  • 申请/专利权人 PACESETTER INC.;

    申请/专利号US201313903846

  • 发明设计人 CECILIA QIN XI;AJIT PILLAI;

    申请日2013-05-28

  • 分类号A61N1/362;A61N1/365;A61N1/37;A61B5/053;

  • 国家 US

  • 入库时间 2022-08-21 15:19:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号